Solid-Phase Synthesis of Isocoumarins
CH2Cl2 (1 mL) and Et3N (5 mL). CuI (0.1 equiv), Pd(PPh3)2Cl2
(0.2 equiv), and alkyne (10 equiv) were added. The reaction mixture
was heated for 16 h at 65 °C. The resin was drained and washed
successively with CH2Cl2 (2 × 5 mL), H2O/DMF (1:1, 2 × 5 mL),
5% DIEA/DMF (2 × 5 mL), MeOH (1 × 5 mL), DMF (1 × 5
mL), MeOH (2 × 5 mL), and CH2Cl2 (2 × 5 mL). Eventually, a
second cycle of reaction was performed depending on the conver-
sion rate determined by HPLC analysis after cleavage of a sample
of resin by TFA/CH2Cl2 (1:1).
A: Typical Procedure for Iodolactonization: Synthesis of
3-Substituted 4-Iodo-1H-isochromen-1-ones. Polymer-bound 2-(alk-
1-ynyl)benzoate (150 mg) was loaded into a polypropylene tube
equipped with a polyethylene frit and swelled in CH2Cl2 for 1 h.
The resin was filtered and suspended in anhydrous CH2Cl2 (3 mL).
A solution of ICl (1.0 M, 1.2 equiv) in CH2Cl2 or I2 (3 equiv) was
added. The suspension was stirred at rt for 4 h, then the resin was
drained and washed with CH2Cl2 (3 × 3 mL). The filtrates were
mixed and treated with 1 mL of aqueous Na2S2O3 (4.0 g in 10 mL
of water). To remove the aqueous phase, the biphasic mixture was
filtered over a cartridge (5 mL) packed with diatomaceous earth.
The recovered organic phase was evaporated under reduced
pressure, yielding the desired 3-substituted 4-iodo-1H-isochromen-
1-ones.
CDCl3) δ 14.0 (CH3), 22.5 (CH2), 29.2 (CH2), 33.4 (CH2), 101.4
(C), 120.5 (C), 125.9 (CH), 128.7 (CH), 130.0 (CH), 135.6 (CH),
136.6 (C), 156.0 (C), 161.7 (C); IR νmax (neat) 1735, 1624, 1475,
1285, 1102, 1051, 1027, 999, 759, 687 cm-1; HPLC tR 3.24 min;
LC-MS (ESI+) m/z (%) 324 (12), 322 [M + CH3CN + H]+ (12),
283 (88), 281 [M + H]+ (100); HRMS (ESI+) m/z calcd for
C13H14O2Br 281.0177, found 281.0175.
1
4-Chloro-3-phenyl-1H-isochromen-1-one, 6b: H NMR (300
MHz, CDCl3) δ 7.43-7.51 (m, 3H), 7.56-7.62 (m, 1H), 7.81-7.89
(m, 3H), 7.94 (d, J ) 8.0 Hz, 1H), 8.33 (dd, J ) 7.9, 1.2 Hz, 1H);
13C NMR (75 MHz, CDCl3) δ 111.5 (C), 120.7 (C), 124.2 (CH),
128.4 (2 × CH), 129.3 (CH), 129.5 (2 × CH), 130.0 (CH), 130.4
(CH), 131.6 (C), 135.5 (CH), 136.1 (C), 150.6 (C), 161.0 (C); IR
ν
max (neat) 1723, 1558, 1489, 1055, 981, 710, 694 cm-1; HPLC tR
3.02 min; LC-MS (ESI+) m/z (%) 300 (3), 298 [M + CH3CN +
H]+ (10), 259 (32), 257 [M + H]+ (100); HRMS (ESI+) m/z calcd
for C15H10O2Cl 257.0369, found 257.0392.
4-Bromo-3-phenyl-1H-isochromen-1-one, 6c12a: 1H NMR (300
MHz, CDCl3) δ 7.40-7.45 (m, 3H), 7.52 (ddd, J ) 7.9, 7.2, 1.3
Hz, 1H), 7.62-7.66 (m, 2H), 7.76 (ddd, J ) 7.9, 7.2, 1.4 Hz, 1H),
7.81-7.86 (m, 1H), 8.25 (dd, J ) 7.9, 0.9 Hz, 1H); 13C NMR (75
MHz, CDCl3) δ 76.8 (C), 120.6 (C), 128.4 (2 × CH), 129.5 (CH),
130.0 (CH), 130.3 (2 × CH), 130.5 (CH), 131.8 (CH), 135.0 (C),
136.0 (CH), 138.5 (C), 155.1 (C), 161.9 (C); IR νmax (neat) 1737,
1619, 1474, 1231, 1086, 1054, 1020, 960, 758, 688 cm-1 HPLC tR
3.01 min; LC-MS (ESI+) m/z (%) 344 (10), 342 [M + CH3CN +
H]+ (10), 303 (99), 301 [M + H]+ (100); HRMS (ESI+) m/z calcd
for C15H10O2Br 300.9864, found 300.9850.
3-Butyl-4-iodo-1H-isochromen-1-one, 5a: 1H NMR (300 MHz,
CDCl3) δ 0.93 (t, J ) 7.3 Hz, 3H), 1.34-1.48 (m, 2H), 1.62-1.76
(m, 2H), 2.88 (t, J ) 7.9 Hz, 2H), 7.45 (ddd, J ) 8.1, 6.7, 1.8 Hz,
1H), 7.66-7.76 (m, 2H), 8.41 (dd, J ) 8.1, 0.7 Hz, 1H); 13C NMR
(75 MHz, CDCl3) δ 14.1 (CH3), 22.0 (CH2), 29.6 (CH2), 37.4 (CH2),
76.4 (C), 120.3 (C), 128.8 (CH), 129.9 (CH), 130.7 (CH), 134.4
(C), 135.9 (CH), 158.5 (C), 162.2 (C); IR νmax (neat) 1731, 1609,
1473, 1177, 1100, 1053, 1029, 982, 759, 687 cm-1; HPLC tR 3.31
min; LC-MS (ESI+) m/z (%) 329 [M + H]+ (100); HRMS (ESI+)
m/z calcd for C13H14O2I 329.0039, found 329.0019.
C: Typical Procedure for Electrocyclization with TFA:
Synthesis of 3-Substituted 4-H-Isochromen-1-ones. The polymer-
bound 2-(alk-1-ynyl)benzoate (150 mg) was swelled in CH2Cl2 for
1 h, filtered, and suspended in a mixture of CH2Cl2/TFA (v/v 1:1,
4 mL). The suspension was stirred at rt for 2 h, then the resin was
drained and washed with CH2Cl2 (3 × 3 mL). The filtrates were
mixed and evaporated under reduced pressure, yielding the desired
3-substituted 4-H-isochromen-1-one.
4-Iodo-3-phenyl-1H-isochromen-1-one, 6a12c: H NMR (300
1
MHz, CDCl3) δ 7.40-7.45 (m, 3H), 7.52 (ddd, J ) 7.9, 7.2, 1.3
Hz, 1H), 7.62-7.66 (m, 2H), 7.76 (ddd, J ) 7.9, 7.2, 1.4 Hz, 1H),
7.81-7.86 (m, 1H), 8.25 (dd, J ) 7.9, 0.9 Hz, 1H); 13C NMR (75
MHz, CDCl3) δ 76.8 (C), 120.6 (C), 128.4 (2 × CH), 129.5 (CH),
130.0 (CH), 130.3 (2 × CH), 130.5 (CH), 131.8 (CH), 135.0 (C),
136.0 (CH), 138.5 (C), 155.1 (C), 161.9 (C); IR νmax (neat) 1725,
1599, 1471, 1231, 1075, 1029, 946, 758, 687 cm-1; HPLC tR 3.06
min; LC-MS (ESI+) m/z (%) 349 [M + H]+ (100); HRMS (ESI+)
m/z calcd for C15H10O2I 348.9726, found 348.9724.
3-Butyl-1H-isochromen-1-one, 5d9g: 1H NMR (300 MHz,
CDCl3) δ 0.90 (t, J ) 7.4 Hz, 3H), 1.31-1.46 (m, 2H), 1.58-1.75
(m, 2H), 2.48 (t, J ) 7.4 Hz, 2H), 6.20 (s, 1H), 7.30 (d, J ) 7.8
Hz, 1H), 7.39 (dd, J ) 8.0, 7.4 Hz, 1H), 7.62 (dd, J ) 7.8, 7.4 Hz,
1H), 8.20 (d, J ) 8.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 14.0
(CH3), 22.3 (CH2), 29.2 (CH2), 33.4 (CH2), 103.1 (CH), 120.4 (C),
125.2 (CH), 127.7 (CH), 129.7 (CH), 134.9 (CH), 137.9 (C), 158.6
(C), 163.3 (C); IR νmax (neat) 1723, 1655, 1483, 1160, 1045, 1022,
755, 690 cm-1; HPLC tR 2.78 min; LC-MS (ESI+) m/z (%) 244
[M + CH3CN + H]+ (23), 203 [M + H]+ (100); HRMS (ESI+)
m/z calcd for C13H15O2 203.1072, found 203.1052.
B: Typical Procedure for Bromo- or Chlorolactonization:
Synthesis of 3-Substituted 4-Bromo- or 4-Chloro-1H-isochromen-
1-ones. The polymer-bound 2-(alk-1-ynyl)benzoate (150 mg) was
swelled in anhydrous ClCH2CH2Cl for 1 h, filtered, and suspended
in anhydrous ClCH2CH2Cl (3 mL). CuX2 (X ) Cl or Br) (4 equiv)
and Cy2NH·HX or Et3N·HX (0.1 equiv) were added. The suspen-
sion was stirred at 65 °C for 16 h, then the resin was drained and
washed with CH2Cl2 (3 × 3 mL). The filtrates were mixed and
passed through a cake of silica gel. The recovered organic phase
was evaporated under reduced pressure, yielding the desired
3-substituted 4-bromo- or 4-chloro-1H-isochromen-1-one.
3-Butyl-4-chloro-1H-isochromen-1-one, 5b: 1H NMR (300
MHz, CDCl3) δ 0.90 (t, J ) 7.4 Hz, 3H), 1.32-1.46 (m, 2H),
1.62-1.75 (m, 2H), 2.74 (t, J ) 7.4 Hz, 2H), 7.45-7.54 (m, 1H),
7.72-7.80 (m, 2H), 8.25 (dd, J ) 7.9, 0.8 Hz, 1H); 13C NMR (75
MHz, CDCl3) δ 14.0 (CH3), 22.5 (CH2), 29.1 (CH2), 31.3 (CH2),
111.2 (C), 120.6 (C), 123.5 (CH), 128.7 (CH), 130.1 (CH), 135.5
(CH), 135.9 (C), 155.0 (C), 162.2 (C); IR νmax (neat) 1740, 1631,
1478, 1271, 1051, 1027, 761, 688 cm-1; HPLC tR 3.22 min; LC-
MS (ESI+) m/z (%) 280 (3), 278 [M + CH3CN + H]+ (11), 239
(32), 237 [M + H]+ (100); HRMS (ESI+) m/z calcd for C13H14O2Cl
237.0682, found 237.0691.
3-Phenyl-1H-isochromen-1-one, 6d9k 1H NMR (300 MHz,
:
CDCl3) δ 6.86 (s, 1H), 7.27-7.52 (m, 5H), 7.64 (m, 1H), 7.80 (m,
2H), 8.16-8.30 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 102.1 (CH),
120.7 (C), 125.4 (2 × CH), 126.3 (CH), 128.4 (CH), 129.1 (2 ×
CH), 129.8 (CH), 130.2 (CH), 132.1 (C), 135.2 (CH), 137.8 (C),
153.8 (C), 162.6 (C); IR νmax (neat) 1717, 1638, 1482, 1238, 1070,
1028, 749, 681 cm-1; HPLC tR 2.74 min; LC-MS (ESI+) m/z (%)
264 [M + CH3CN + H]+ (7), 223 [M + H]+ (100); HRMS (ESI+)
m/z calcd for C15H11O2 223.0759, found 223.0775.
Acknowledgment. This study and postdoctoral fellowship
of M.P. were supported by grants from the Agence Nationale
de la Recherche (Contract ANR-06-PCVI-0028-02). The authors
thank Pierre Sanchez for performing mass spectrometry analyses.
Supporting Information Available: Experimental details and
1H and 13C NMR spectral data for described compounds. This
material is available free of charge via the Internet at
4-Bromo-3-butyl-1H-isochromen-1-one, 5c: 1H NMR (300
MHz, CDCl3) δ 0.92 (t, J ) 7.3 Hz, 3H), 1.32-1.45 (m, 2H),
1.63-1.74 (m, 2H), 2.88 (t, J ) 7.6 Hz, 2H), 7.44-7.51 (m, 1H),
7.71-7.79 (m, 2H), 8.22 (d, J ) 7.8 Hz, 1H); 13C NMR (75 MHz,
JO900281A
J. Org. Chem. Vol. 74, No. 11, 2009 4165